Stephen Cook

Stephen Cook

Auto-generated profile, based on publicly available information

Stephen Cook

Department of Laboratory Medicine, San Francisco Veterans Affairs Health Care System , San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Academic Pediatrics
Verified
Journal Article
Closed access
EGEmily Guseman
Emily Guseman
JEJoey C. Eisenmann
Joey C. Eisenmann
KLKelly R. Laurson
Kelly R. Laurson
SCStephen R. Cook
Stephen R. Cook
WSWilliam Stratbucker
William Stratbucker

2 January 2018 in Journal of Hunger & Environmental Nutrition
Verified
Journal Article
Open access
KEKristin Evans
Kristin Evans
PSPatricia Stewart
Patricia Stewart
SCStephen Cook
Stephen Cook
CSChristopher Seplaki
Christopher Seplaki
DRDavid Rich
David Rich
Israel Fernández LópezIsrael Fernández López
Israel Fernández López
The objective of this study was to compare grocery costs between relatively high-energy-density foods and sugar-sweetened/high-fat beverages and lower energy-density foods and more healthful beverages in children’s diets. Sixty foods were divided into high- and low-energy-density baskets. Fourteen beverages were designated to either basket based on fat and added-sugar content. Prices were collected at 60 grocery stores and composite costs compared between baskets using Wilcoxon tests. The cost per kilogram of high-energy-density foods was greater, but the cost per quart of sugar-sweetened/high-fat beverages was lower than more healthful beverages. The cost per 1000 calories and the cost per serving of the high-energy-density basket were lower. The relative cost of high- and low-energy-density foods in children’s diets depends on how cost is quantified. “Pound-for-pound,” lower energy-density foods and more healthful beverages are generally less expensive, but high-energy-density foods and less healthful beverages are cheaper per serving. Cost metrics including other factors (eg, time cost) may further clarify the role of grocery prices in children’s diets.

11 April 2022 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
SCStephen Cook
Stephen Cook
A 44-year-old man with a history of Grave disease presented with tachycardia, weight loss, and dysphagia. He was diagnosed with severe hyperthyroidism, diabetic ketoacidosis, and hyponatremia ( Table 1). A complete blood count was performed and the hemoglobin, mean cell hemoglobin (MCH), and MCH concentration (MCHC) were flagged for review due to MCHC >37.5 g/dL. Smear review was normal, and the sample was prewarmed at 37°C with similar results. What are potential causes of an increased MCHC? Why does a markedly increased MCHC result serve as a flag for automated hematology analyzers? What is the most likely cause of the increased MCHC in this patient? The answers are below. Causes of high MCHC include red blood cell agglutination, hemolysis, lipemia, icterus, leukocytosis, spherocytosis, and electrolyte abnormalities ( 1). The high MCHC flag serves to detect interference in hemoglobin, hematocrit, mean cell volume, MCH, and MCHC. Hyponatremia can cause an artificially high MCHC and this was suspected in this patient. Hyponatremia can cause in vitro shrinking of the red blood cells due to osmolality differences between patient plasma and reagent diluent, leading to a falsely low hematocrit, low mean cell volume, and high MCHC ( 2–4).

25 November 2019 in Human Pathology: Case Reports
Verified
Journal Article
Open access
PDF file
CMCristiane B. Milito
Cristiane B. Milito
FBFrancisco Beca
Francisco Beca
YNYasodha Natkunam
Yasodha Natkunam
SCStephen Cook
Stephen Cook
We report a case of breast implant-associated anaplastic large cell lymphoma in a 70-year old woman, who 21 years previously had undergone bilateral breast augmentation with textured silicone implants. Eleven years later, she had bilateral implant removal with possible implant leak and presence of ‘atypical cells’ in the seroma. She then opted for prophylactic bilateral mastectomy in view of her strong family history of breast cancer and underwent reconstruction with subcutaneous gel implants. Eight months later, the patient noted right breast swelling and peri-implant effusion. The cytology was suspicious for lymphoma. Bilateral implant removal and capsulectomy was performed and a breast implant-associated anaplastic large cell lymphoma was diagnosed. Due to the lack of surrounding breast tissue after mastectomy, it was not possible to thoroughly sample or evaluate breast parenchymal involvement by the lymphoma, an important consideration in determining aggressivity. The decision was made to initiate Brentuximab vedotin therapy.